Collectively, these findings underscore the contribution of PAI-1 to the acquisition of the aggressive phenotype and shed light on the consistent inclusion of PAI-1 among the biomarkers of poor prognosis and reduced disease-free survival times in cancer patients. This evidence concerns the gene SERPINE1 and cancer.